Differential receipt of sentinel lymph node biopsy within practice-based research networks

Medical Care

Volumn 51, Issue 9, 2013, Pages 812-818

  Meyer, Anne Marie ^a,b   Reeder Hayes, Katherine E ^b,c   Liu, Huan ^b   Wheeler, Stephanie B ^a,b   Penn, Dolly ^d   Weiner, Bryan J ^a,b   Carpenter, William R ^a,b  

^a University of North Carolina at Chapel Hill   (United Kingdom)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Loma Linda University   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Community Clinical Oncology Program (CCOP); Epidemiology; Practice based research networks (PBRN); SEER Medicare; Sentinel lymph node biopsy

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURGERY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEDICAL RESEARCH; PARTIAL MASTECTOMY; PHYSICIAN; PRACTICE BASED RESEARCH NETWORK; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; UTILIZATION REVIEW;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMMUNITY-INSTITUTIONAL RELATIONS; CONTINENTAL POPULATION GROUPS; DIFFUSION OF INNOVATION; FEMALE; HUMANS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; UNIVERSITIES;

EID: 84883260819     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31829c8ca4     Document Type: Article

References (28)

1. Institute of Medicine. Ensuring Quality Cancer Care. Washington, DC: National Academies Press; 1999.
2. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001.
3. Institute of Medicine. Statement on Quality of Care. Washington, DC: National Academies Press; 1998.
4. Westfall JM, Mold J, Fagnan L. Practice-based research - "Blue Highways" on the NIH roadmap. JAMA. 2007;297: 403-406.
5. Zerhouni E. The NIH Roadmap. Science. 2003;302: 63-72.
6. Lanier D. Practice-based research networks: laboratories for improving colorectal cancer screening in primary care practice. Med Care. 2008;46(suppl 1):S147-S152.
7. Sales A, Smith J, Curran G, et al. Models, strategies, and tools. Theory in implementing evidence-based findings into health care practice. J Gen Intern Med. 2006;21(suppl 2):S43-S49.
8. Minasian LM, Carpenter WR, Weiner BJ, et al. Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program. Cancer. 2010;116: 4440-4449.
9. Edge SB, Niland JC, Bookman MA, et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst. 2003;95: 1514-1521.
10. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23: 7703-7720.
11. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet. 1999;354: 896-900.
12. Vanderveen KA, Paterniti DA, Kravitz RL, et al. Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol. 2007; 14: 1662-1669.
13. Wright FC, Gagliardi AR, Fraser N, et al. Adoption of surgical innovations: factors influencing use of sentinel lymph node biopsy for breast cancer. Surg Innov. 2011;18: 379-386.
14. Carpenter WR, Reeder-Hayes K, Bainbridge J, et al. The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Med Care. 2011;49: 172-179.
15. Reeder-Hayes KE, Bainbridge J, Meyer AM, et al. Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat. 2011;128: 863-871.
16. McFall SL, Warnecke RB, Kaluzny AD, et al. Physician and practice characteristics associated with judgments about breast-cancer-treatment. Med Care. 1994;32: 106-117.
17. Mandelblatt JS, Berg CD, Meropol NJ, et al. Measuring and predicting surgeons' practice styles for breast cancer treatment in older women. Med Care. 2001;39: 228-242.
18. Ayanian JZ, Guadagnoli E. Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat. 1996; 40: 65-74.
19. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(suppl):IV-3-IV-18.
20. National Cancer Institute. SEER-Medicare Publications, 2011. Available at: http://healthservices.cancer.gov/seermedicare/overview/publica tions.html. Accessed September 9, 2012.
21. Carpenter WR, Meyer AM, Abernethy AP, et al. A framework for understanding cancer comparative effectiveness research data needs. J Clin Epidemiol. 2012;65: 1150-1158.
22. Carpenter WR, Meyer AM, Wu Y, et al. Translating research into practice the role of provider-based research networks in the diffusion of an evidencebased colon cancer treatment innovation. Med Care. 2012;50: 737-748.
23. Banerjee M, George J, Yee C, et al. Disentangling the effects of race on breast cancer treatment. Cancer. 2007;110: 2169-2177.
24. Wheeler SB, Carpenter WR, Peppercorn J, et al. Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer. Breast Cancer Res Treat. 2012;131: 207-216.
25. Wheeler SB, Wu Y, Meyer AM, et al. Use and timeliness of radiation therapy after breast-conserving surgery in low-income women with early-stage breast cancer. Cancer Invest. 2012;30: 258-267.
26. Bach PB, Guadagnoli E, Schrag D, et al. Patient demographic and socioeconomic characteristics in the SEER-Medicare database - applications and limitations. Med Care. 2002;40: 19-25.
27. Keating NL, Kouri E, He YL, et al. Racial differences in definitive breast cancer therapy in older women are they explained by the hospitals where patients undergo surgery? Med Care. 2009;47: 765-773.
28. Klabunde CN, Legler JM, Warren JL, et al. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007;17: 584-590.